zoledronic acid has been researched along with atrasentan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carducci, MA; Walczak, JR | 1 |
| Kantoff, P; Kaufman, DS; Michaelson, MD; Oh, WK; Smith, MR | 1 |
1 review(s) available for zoledronic acid and atrasentan
| Article | Year |
|---|---|
Pharmacological treatments for prostate cancer.
Topics: Antibodies, Monoclonal; Atrasentan; Dendritic Cells; Diphosphonates; Genetic Therapy; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imidazoles; Male; Microtubules; Prostatic Neoplasms; Pyrrolidines; Radiopharmaceuticals; Zoledronic Acid | 2002 |
1 trial(s) available for zoledronic acid and atrasentan
| Article | Year |
|---|---|
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Disease Progression; Dyspnea; Edema; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Treatment Outcome; Zoledronic Acid | 2006 |